Martina Novotna, MD, Moses Rodriguez, MD, and Orhun H. Kantarci, MD
October 2015—Current immunomodulatory treatments for MS are not reliable to prevent long-term disability, but future agents focusing on remyelination and axonal and neuronal repair could reverse this course.
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
BRYN MAWR COMMUNICATIONS III, LLC